Night-to-Night Variability of Muscle Tone, Movements, and Vocalizations in Patients with REM Sleep Behavior Disorder
2010; American Academy of Sleep Medicine; Volume: 06; Issue: 06 Linguagem: Inglês
10.5664/jcsm.27988
ISSN1550-9397
AutoresFanny Cygan, Delphine Oudiette, Laurène Leclair‐Visonneau, Smaranda Leu‐Semenescu, Isabelle Arnulf,
Tópico(s)Genetic Neurodegenerative Diseases
ResumoFree AccessREM Sleep Behavior DisorderNight-to-Night Variability of Muscle Tone, Movements, and Vocalizations in Patients with REM Sleep Behavior Disorder Fanny Cygan, Delphine Oudiette, Laurène Leclair-Visonneau, Smaranda Leu-Semenescu, M.D., Isabelle Arnulf, M.D., Ph.D. Fanny Cygan Sleep Disorder Unit, Pitié-Salpêtrière Hospital, APHP, and Centre de Recherche de l'Institut du Cerveau et de la Moelle epiniere, UPMC-Paris 6; Inserm UMR_S 975; CNRS UMR 7225, France , Delphine Oudiette Sleep Disorder Unit, Pitié-Salpêtrière Hospital, APHP, and Centre de Recherche de l'Institut du Cerveau et de la Moelle epiniere, UPMC-Paris 6; Inserm UMR_S 975; CNRS UMR 7225, France , Laurène Leclair-Visonneau Sleep Disorder Unit, Pitié-Salpêtrière Hospital, APHP, and Centre de Recherche de l'Institut du Cerveau et de la Moelle epiniere, UPMC-Paris 6; Inserm UMR_S 975; CNRS UMR 7225, France , Smaranda Leu-Semenescu, M.D. Sleep Disorder Unit, Pitié-Salpêtrière Hospital, APHP, and Centre de Recherche de l'Institut du Cerveau et de la Moelle epiniere, UPMC-Paris 6; Inserm UMR_S 975; CNRS UMR 7225, France , Isabelle Arnulf, M.D., Ph.D. Address correspondence to: Isabelle Arnulf, Pathologies du Sommeil, Hôpital Pitié-Salpêtrière, 47 Boulevard de l'Hôpital, 75013 Paris, France E-mail Address: [email protected] Sleep Disorder Unit, Pitié-Salpêtrière Hospital, APHP, and Centre de Recherche de l'Institut du Cerveau et de la Moelle epiniere, UPMC-Paris 6; Inserm UMR_S 975; CNRS UMR 7225, France Published Online:December 15, 2010https://doi.org/10.5664/jcsm.27988Cited by:64SectionsAbstractPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutABSTRACTObjectives:The video-polysomnographic criteria of REM sleep behavior disorder (RBD) have not been well described. We evaluated the between-night reproducibility of phasic and tonic enhanced muscle activity during REM sleep as well as the associated behaviors and vocalizations of the patients.Methods:Fifteen patients with clinical RBD underwent two consecutive video-polysomnographies. The amount of excessive phasic and tonic chin muscle activity during REM sleep was measured in 15 patients in 3-sec mini-epochs. The time spent with motor (minor, major, complex, and scenic) or vocal (sounds, mumblings, and comprehensible speeches) events was measured in 7 patients during REM sleep.Results:There was a good between-night agreement for tonic (Spearman rho = 0.55, p = 0.03; Kendall tau = 0.48, p = 0.01) but not for phasic (rho = 0.47, p = 0.1; tau = 0.31, p = 0.1) excessive chin muscle activity. On the video and audio recordings, the minor RBD behaviors tended to occur more frequently during the second night than the first, whereas the patients spoke longer during the first than the second night.Conclusion:The excessive tonic activity during REM sleep is a reliable marker of RBD. It could represent the extent of dysfunction in the permissive atonia systems. In contrast, the more variable phasic activity and motor/vocal events could be more dependent on dream content (executive systems).Citation:Cygan F; Oudiette D; Leclair-Visonneau L; Leu-Semenescu S; Arnulf I. Night-to-night variability of muscle tone, movements, and vocalizations in patients with REM sleep behavior disorder. J Clin Sleep Med 2010;6(6):551-555.INTRODUCTIONREM sleep behavior disorder (RBD) is a recently described parasomnia characterized by violent, or potentially violent, movements during REM sleep, mostly corresponding to enacted dreams. During sleep monitoring, there is a partial or total loss of normal muscle atonia during REM sleep.1 REM sleep behavior disorder predominantly affects elderly subjects without any other disease (idiopathic RBD) or suffering from various neurological and neurodegenerative diseases, mainly synucleinopathies.2 Because the RBD symptoms may indicate a future neurodegenerative disease such as Parkinson disease, dementia with Lewy bodies, and multiple system atrophy,3 there is a need for accurate diagnostic criteria for the disorder. In this regard, the recent diagnostic consensus indicates that a history of sleep related injurious, potentially injurious, or disruptive behaviors should be associated with the presence of REM sleep without atonia.1 The latter is defined in practice as excessive sustained or intermittent elevation of chin electromyographic (EMG) tone or excessive phasic chin or limb EMG twitching.1 However, the methods for scoring enhanced muscle tone and the cut-off for abnormal muscle tone were not defined in this classification. More recently, the measure of tonic muscle activity in REM sleep was defined as the sum of REM sleep epochs with ≥ 50% of the duration of the epoch having a chin EMG amplitude greater than the minimum amplitude in NREM sleep.4 The enhanced phasic chin muscle activity in REM sleep was defined as the percentage of 30-sec epochs containing ≥ five 3-sec mini-epochs with bursts of transient muscle activity. A transient muscle activity was an enhancement of EMG signal ≥ 4 times as high in amplitude as the background EMG activity, lasting 0.1 to 5 sec. When contrasting muscle activity during REM sleep in 33 patients with Parkinson disease (with and without RBD) and 16 healthy controls, it was suggested that 20% of REM sleep without atonia be defined as abnormal.5 When combining the tonic and phasic muscle activity, and using mini-epochs of 3 sec instead of 2 sec in 17 patients, Consens et al. found that a cut-off of 10% is more sensitive to diagnose RBD.6 Because a recent study showed that the amount of tonic muscle activity during REM sleep predicts the future development of Parkinson disease in idiopathic RBD,7 it is important to determine if one night is sufficient for the diagnosis, or if the sleep test should be repeated to enhance the accuracy of RBD diagnosis. The night-to-night variability in tonic and phasic muscle tone is also an important factor to take into account when calculating the power and size of drug or interventions against RBD. When studying 2 consecutive nights, the tonic, phasic, and combined muscle activity measured on Night 1 closely correlated with the same measures on Night 2 in 17 patients at risk for RBD and 6 controls.6 However, an agreement (rather than a correlation) between diagnosis on both nights may be more appropriate to evaluate if one measure is sufficient or not. In a previous study using 55 patients with RBD, a threshold ≥ 10% enhanced tonic (or phasic plus tonic) muscle submental activity yielded a positive diagnosis of RBD in 80% of patients during the first night.8 This percentage was increased to 95% when combining the polysomnography results with the videos. We aimed to replicate these results in our series of patients with clinically suspected RBD, and to measure night-to-night variability in motor and vocal behaviors.BRIEF SUMMARYCurrent Knowledge/Study Rationale: It is not yet determined if a single night-time video and sleep monitoring are sufficient for diagnosing REM sleep behavior disorder (RBD). Plus, the night-to-night variability of chin muscle tonic and phasic activity, as well as movements and vocalizations during REM sleep, is unknown.Study Impact: As the enhanced tonic muscle activity during REM sleep is a more reliable marker of RBD between nights than the phasic activities (chin muscle, movements and speeches), it can be used as a marker of efficacy in future drug trials in RBD. Plus, it shows that one night is enough for diagnosing RBD.METHODSSubjectsEighteen patients with RBD underwent 2 consecutive nights with video- and sleep- polysomnography. Diagnosis of RBD was confirmed by clinical interview plus video-polysomnography and defined as one of the following: a history of sleep related injurious, potentially injurious, or disruptive behavior; the presence of REM sleep without atonia; and the absence of EEG epileptiform activity during REM sleep.1 To be included in the test-retest study, patients had to present ≥ 5 min of REM sleep time during both nights and to have measurable EMG tone for at ≥ 95% of REM sleep time. Eventually, 15/18 patients met these criteria and were included in the study. They had idiopathic RBD (n = 9), idiopathic Parkinson disease (n = 4), and idiopathic narcolepsy (n = 2); 12 of 15 (80%) were men. Patients were 54 to 81 years old, with a mean age of 66.3 ± 10.2 years and a mean body mass index of 26.6 ± 4.5 kg/m2. Prescribed medications included antidepressants (n = 6) and melatonin (n = 3), unchanged during the 2 nights. No patients were taking benzodiazepines. The mean score of the group on the Epworth Sleepiness Scale was 10.0 ± 5.2, and 53.3% of the patients had a score ≥ 10.Video and sleep monitoringAll patients underwent a video-polysomnography on 2 consecutive nights. The monitoring included the following: Fp1-A2, C3-A2, C3-O1 electroencephalography; electro-oculography (2 channels); levator menti and tibialis anterior muscle electromyography; nasal pressure though a cannula; tracheal sounds through a microphone; thoracic and abdominal belts to assess respiratory efforts; electrocardiography; pulse oximetry; EEG-synchronized infrared video-monitoring; and ambiance microphone.ScoringThe sleep stages, arousals, alpha rhythm on EEG, respiratory events, and periodic leg movements were scored by visual inspection according to standard criteria,4 with allowance for scoring REM sleep despite persistence of tonic and phasic muscle activity, according to the international criteria. Tonic and phasic muscle activities were quantified during REM sleep using the EMG chin channel.9 The periods of REM sleep with a microarousal or snoring artifact were removed from the analysis. The tonic enhanced muscle activity was scored on 30-sec epochs. The epochs were scored as tonic when the background EMG activity was 2 times greater than in stage N3 during ≥ 50% of the epoch. The phasic enhanced EMG activity was evaluated in 3-sec mini-epochs during REM sleep, and any burst 4 times greater than the epoch background EMG activity, lasting between 0.1 and 5 sec, was counted. To be considered as distinct events, 2 phasic events had to be separated by at least one second. The phasic REM sleep activity (in percent) was the sum of all mini-epochs containing enhanced muscle activity, divided by the REM sleep time. We did not combine the phasic and tonic activities, as they could be superimposed in the same patient, which would lead to a sum > 100%. We measured the proportion of REM sleep time during which movements and behaviors were apparent and also noted the type of behaviors. For this purpose, we scrutinized, second-by-second, the videos obtained during REM sleep for 7 patients with RBD over 2 consecutive nights. When we observed a movement or a vocalization (regardless of type, amplitude, and duration), we put a marker at the start and end of the event and determined the event duration. Motor events were classified according to complexity as previously described.10 The behaviors were considered minor when they were myoclonic or too simple to be noticed by the bed partner (e.g., finger twitch). They were major when their amplitude was large or when more than one limb was moving (e.g., large arm movement or whole body jerk). Complex behaviors were behaviors that involved apparent "acting out" of a dream but were not clear enough to determine the exact meaning of the behavior (e.g., multiple disordered gestures of the superior limbs). Scenic behaviors were behaviors that involved "acting out" the dream and were easily understood by the observer (e.g., mimicking the gesture of smoking a cigarette). The vocalizations were classified according to articulation (sounds, mumblings, or words). The side of the limb movements was noted.StatisticsAs no measures were normally distributed, we compared the measures by Wilcoxon signed rank (with correction for multiple testing) and tested their agreement between nights by using the Kendall tau coefficient and the Spearman rho. Data are shown as mean ± standard deviation or frequencies (percentage). Between-nights change is calculated as the measure during the second night minus the measure during the first night (in absolute value), divided by the measure during the first night. It is expressed as a percentage.RESULTSNight-to-Night Variability of Sleep MeasuresAs shown in Table 1, the patients had a higher percentage of N3 sleep during the second night than the first. The sleep duration, efficiency, sleep onset, and REM sleep latencies, as well as N1, N2, and REM sleep percentages were not different between nights. Over the whole group, REM sleep time was 77.9 ± 27.6 min (range 6-118 min) during Night 1 and 77.4 ± 40.8 min (range 18-144 min) during Night 2, which was a nonsignificant change.Table 1 Sleep measures during two consecutive nights in 15 patients with RBDNight 1Night 2Individual night to night changepNumber of patients1515Total sleep time, min403.9 ± 83.1385.4 ± 131.219 ± 21%0.8Total sleep period, min542.2 ± 110.8529.00 ± 110.823 ± 16%0.8Sleep efficiency, %75.4 ± 12.969.1 ± 23.918.8 ± 18.7%0.07Latency to Sleep onset, min46.0 ± 40.336.1 ± 26.455.3 ± 54.6%0.4 REM sleep, min143.1 ± 137.3131.7 ± 150.151 ± 64%0.2Sleep stages, % of total sleep time N17.7 ± 5.17.1 ± 5.564 ± 70%0.4 N248.1 ± 7.647.4 ± 9.111 ± 8%0.9 N322.7 ± 6.126.99 ± 7.9326 ± 23%0.03* REM sleep21.1 ± 7.718.5 ± 8.928 ± 23%0.2REM sleep time, min77.9 ± 27.677.4 ± 40.8184 ± 586%0.7Quantification of tonic and phasic muscle activity REM sleep with tonic activity, %45.9 ± 28.442.6 ± 26.146 ± 44%0.7 REM sleep with phasic activity, %20.9 ± 5.223.6 ± 5.928 ± 31%0.1Night-to-Night Variability of Phasic and Tonic Muscle Activity during REM SleepThere was no difference between Night 1 and Night 2 in terms of percentages of tonic and phasic muscle activity during REM sleep. There was a 46% between-night change in tonic enhanced muscle activity and a 28% change in phasic muscle activity. Figure 1A and Figure 1B illustrate the between-night correlations for tonic and phasic muscle activity.Figure 1 Tonic (A) and phasic (B) enhanced muscle activity, as a percent of REM sleep time, during Night 1 (x axis) and Night 2 (y axis)Download FigureAs indicated in Table 2, the Kendall tau coefficient was significant (meaning that there was a good between-night agreement) for tonic but not for phasic activity. Similarly, the Spearman rho coefficient was significant (p = 0.03) for tonic but not (p = 0.1) for phasic muscle activity during REM sleep.Table 2 Between-night concordance for RBD-related measures, as a percent of REM sleep timeKendall tau coefficientSpearman rho coefficientREM sleep without atonia, % (n = 15) Phasic0.310.47 Tonic0.48*0.55*Duration of behaviors, % (n = 7) All0.240.21 Minor0.430.50 Major0.330.46 Complex0.390.50 Scenic−0.28−0.38Duration of vocalizations, % (n = 7) All0.050.28 Mumbling0.290.57 Sounds−0.24−0.43 Comprehensible speech0.090.05*p < 0.05Night-to-Night Variability in RBD-Associated Behaviors and VocalizationsIn the video and audio recordings (Table 3), the RBD-associated behaviors represented 8.1% ± 6% of REM sleep time during the first night (range: 2% to 19%; 1.4-11.6 min), and increased (p = 0.4) to 8.7% ± 4.9% the second night (range: 3% to 16%; 1.3-21.0 min), but this change was not significant. Only 0.9% of the time was spent in scenic behaviors, whereas complex and major behaviors were more frequent. There were no between-night differences in the time and proportion of these behaviors. The vocalizations during RBD contained mainly comprehensible words and sentences, followed by mumbling and sounds. There were no difference in the frequency of these vocalizations between the first and the second night, except that patients tended to speak (with a comprehensible speech) more during the first than the second night. There was a weak, but not significant, correlation between nights for the duration of all types of behaviors, sounds, and mumbling. The time spent speaking did not, however, correlate between nights (rho = 0.09, p = 0.1). Most limb movements were bilateral, and the left and right limbs were used as frequently, with no difference between nights.Table 3 Comparison of REM sleep behaviors in 7 patients between Night 1 and Night 2Night 1Night 2Individual night-to-night changep valueNumber of patients77REM sleep duration, min74.6 ± 18.681.3 ± 57.242 ± 29%0.7Duration of behavior, % of total REM sleep time All8.1 ± 6.08.7 ± 4.997 ± 183%0.65 Minor3.6 ± 3.44.6 ± 2.8169 ± 202%0.06 Major2.1 ± 1.82.1 ± 2.4119 ± 189%0.7 Complex1.5 ± 1.11.7 ± 1.888 ± 76%0.7 Scenic0.9 ± 1.30.4 ± 0.543 ± 53%0.4Duration of vocal type behavior, % of total REM sleep time All3.6 ± 0.033.0 ± 0.03173 ± 296%0.3 Sound0.9 ± 0.020.6 ± 0.01140 ± 296%0.3 Mumbling1.2 ± 0.011.5 ± 0.02160 ± 222%0.4 Comprehensible speech1.5 ± 0.010.8 ± 0.01914 ± 2226%0.06Behavior laterality, % of total behaviors Both52.5 ± 0.250.0 ± 0.319 ± 21%0.7 Left21.6 ± 0.126.5 ± 0.256 ± 79%0.7 Right26.0 ± 0.123.5 ± 0.241 ± 36%0.7DISCUSSIONIn 15 patients with RBD, the rate of tonic enhanced muscle activity during REM sleep remained stable between the first and second night, with a correlation of 0.48. However, the percent of phasic enhanced muscle activity and the time spent with abnormal behaviors and vocalizations during REM sleep was not reproducible between nights. In particular, the minor RBD behaviors tended to be more frequent during the second night, whereas the patients spoke longer during the first night.The night-to-night changes in total sleep time and REM sleep percentage were small and not significant in our sample, as shown in a previous study of patients with RBD.8 These results suggest that the "first-night effect" is not a problem in patients with RBD, except for the percent of N3 sleep. This effect is believed to result from sleeping for the first time with electrodes in an unfamiliar environment. It is characterized by a decreased quality and quantity of first-night sleep as indicated by more stage 1 and intra-sleep wake, paralleled by reduced sleep efficiency and longer sleep onset latency.11 Although there are numerous reports that suggest that sleeping at home or in a hotel room (rather than in the sleep laboratory) minimizes the first-night effect,12 this option of home recording cannot be offered to patients with suspicion of RBD, as there is yet no easy means of simultaneously monitoring the behavior with an infrared video and the electrophysiological measures at home. The time and percentage of REM sleep is one of the key measures, as far as the diagnosis of RBD is concerned. Here, the REM sleep time and percentage were similar between nights, provided that a minimum of 5 min of REM sleep had been observed during both nights.There was a moderate change and good agreement in the percentage of enhanced tonic chin muscle activity during REM sleep between the 2 nights. This result is important because tonic muscle activity during REM sleep is a widely used measure, especially in patients with idiopathic RBD, as it can predict the later development of Parkinson disease.7 We found a mean 44% enhanced chin tonic muscle activity during REM sleep in our series, which is close to percentages reported in other RBD groups in Western countries,3,6,7,13 but is double that reported in an Asian series.8 Because the methods for measuring muscle activities are identical, these differences suggest that Asian patients have decreased muscle activity during RBD, or that patients with less severe RBD were included. The stability and reproducibility of tonic REM sleep muscle activity suggests that it is a state marker for RBD. It could possibly represent the extent of the damage (neuronal loss or dysfunction) to the REM sleep atonia system.In contrast to the tonic muscle activity, which had a good (0.48-0.55) night-to-night agreement, the phasic chin muscle activity changed significantly (with a mean 28% change) between the first and the second night. This result is different from a previous study,8 which reported nonsignificant differences for phasic muscle activity between Night 1 and Night 2 in 50 patients with RBD. The mean phasic activity in the RBD group was, however, lower (9% vs. 22%) than in our sample, and the agreement between phasic measures was not tested. The frequency and complexity of behaviors and vocalizations also varied between nights in our sample, with more time spent with minor behaviors during the second night than the first, and longer speeches during the first night than the second. The between-night reproducibility of behaviors and speeches has not been tested in other series, to the best of our knowledge. Altogether, these results suggest that the brain systems generating these phasic activities (chin muscle phasic activity, limb movements, and vocalizations) during REM sleep are more variable than the atonia system. This finding may suggest that the atonia system is permissive and damaged in RBD, whereas the phasic system is executive and dysfunctional, rather than damaged. Alternatively, the phasic activity during REM sleep may depend on the nature and between-night variability of the dreaming process, if one assumes that most dreams are translated into visible behaviors. It is notable that REM sleep dream content is highly variable among subjects and between nights.14There are several limitations in this study, including a small sample size (n = 15), especially for behavioral aspects (n = 7), but these time-consuming, detailed measures of movements and vocalizations have previously yielded important and reproducible results in samples as small as 5 patients.9,10 In addition, our sample includes patients with various diseases, including idiopathic RBD and RBD associated with Parkinson disease and narcolepsy, some of them taking antidepressants. It is a realistic, clinically based sample. The sample size is, however, too small to allow measuring between-night variability in homogenous diseases.In conclusion, enhanced tonic chin muscle activity seems to be a reliable measure for RBD diagnosis, whereas enhanced phasic chin muscle activity as well as motor and vocal behaviors during REM sleep are more variable between nights.DISCLOSURE STATEMENTThis was not an industry supported study. Dr. Arnulf has received research support from Actelion and has participated in speaking engagements for UCB. Dr. Leu-Semenescu has received research support from Bioprojet.REFERENCES1 American Academy of Sleep MedicineThe international classification of sleep disorders, revised: diagnostic and coding manual20052nd edWestchester, ILAmerican Academy of Sleep MedicineGoogle Scholar2 Boeve BFSilber MHSaper CB, et al.Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative diseaseBrain2007130277088, 17412731CrossrefGoogle Scholar3 Iranzo AMolinuevo JLSantamaria J, et al.Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive studyLancet Neurol200655727, 16781987CrossrefGoogle Scholar4 Iber CAncoli-Israel SChesson AQuan SThe AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications20071st edWestchester, ILAmerican Academy of Sleep MedicineGoogle Scholar5 Gagnon JFBedard MAFantini ML, et al.REM sleep behavior disorder and REM sleep without atonia in Parkinson's diseaseNeurology2002595859, 12196654CrossrefGoogle Scholar6 Consens FBChervin RDKoeppe RA, et al.Validation of a polysomnographic score for REM sleep behavior disorderSleep2005289937, 16218083CrossrefGoogle Scholar7 Postuma RBGagnon JFVendette MFantini MLMassicotte-Marquez JMontplaisir JQuantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorderNeurology2009721296300, 19109537CrossrefGoogle Scholar8 Zhang JLam SPHo CK, et al.Diagnosis of REM sleep behavior disorder by video-polysomnographic study: is one night enough?Sleep200831117985, 18714790Google Scholar9 Lapierre OMontplaisir JPolysomnographic features of REM sleep behavior disorder: development of a scoring methodNeurology19924213714, 1620348CrossrefGoogle Scholar10 Frauscher BGschliesser VBrandauer E, et al.Video analysis of motor events in REM sleep behavior disorderMov Disord200722146470, 17516467CrossrefGoogle Scholar11 Curcio GFerrara MPiergianni AFratello FDe Gennaro LParadoxes of the first-night effect: a quantitative analysis of antero-posterior EEG topographyClin Neurophysiol2004115117888, 15066543CrossrefGoogle Scholar12 Sharpley ALSolomon RACowen PJEvaluation of first night effect using ambulatory monitoring and automatic sleep stage analysisSleep1988112736, 3399780CrossrefGoogle Scholar13 Frauscher BIranzo AHogl B, et al.Quantification of electromyographic activity during REM sleep in multiple muscles in REM sleep behavior disorderSleep20083172431, 18517042CrossrefGoogle Scholar14 Domhoff BKryger MDement WCThe content of dreams: methodological and theorical implicationsPrinciples and practice of sleep medicine20054th edPhiladelphiaElsevier Saunders1517Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Actigraphy Enables Home Screening of Rapid Eye Movement Behavior Disorder in Parkinson's DiseaseRaschellà F, Scafa S, Puiatti A, Martin Moraud E and Ratti P Annals of Neurology, 10.1002/ana.26517, Vol. 93, No. 2, (317-329), Online publication date: 1-Feb-2023. Ambulatory Detection of Isolated Rapid‐Eye‐Movement Sleep Behavior Disorder Combining Actigraphy and QuestionnaireBrink‐Kjaer A, Gupta N, Marin E, Zitser J, Sum‐Ping O, Hekmat A, Bueno F, Cahuas A, Langston J, Jennum P, Sorensen H, Mignot E and During E Movement Disorders, 10.1002/mds.29249, Vol. 38, No. 1, (82-91), Online publication date: 1-Jan-2023. Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigationLevendowski D, Walsh C, Boeve B, Tsuang D, Hamilton J, Salat D, Berka C, Lee-Iannotti J, Shprecher D, Westbrook P, Mazeika G, Yack L, Payne S, Timm P, Neylan T and St. Louis E Sleep Medicine, 10.1016/j.sleep.2022.09.025, Vol. 100, , (501-510), Online publication date: 1-Dec-2022. Restricted truncal sagittal movements of rapid eye movement behaviour disorderWasserman D, Gullone S, Duncan I, Veronese M, Gnoni V, Higgins S, Birdseye A, Gelegen E, Goadsby P, Ashkan K, Ray Chaudhuri K, Tononi G, Drakatos P and Rosenzweig I npj Parkinson's Disease, 10.1038/s41531-022-00292-0, Vol. 8, No. 1 Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study GroupCesari M, Heidbreder A, St. Louis E, Sixel-Döring F, Bliwise D, Baldelli L, Bes F, Fantini M, Iranzo A, Knudsen-Heier S, Mayer G, McCarter S, Nepozitek J, Pavlova M, Provini F, Santamaria J, Sunwoo J, Videnovic A, Högl B, Jennum P, Christensen J and Stefani A Sleep, 10.1093/sleep/zsab257, Vol. 45, No. 3, Online publication date: 14-Mar-2022. White matter microstructure in Parkinson's disease with and without elevated rapid eye movement sleep muscle tonePatriat R, Pisharady P, Amundsen-Huffmaster S, Linn-Evans M, Howell M, Chung J, Petrucci M, Videnovic A, Holker E, De Kam J, Tuite P, Lenglet C, Harel N and MacKinnon C Brain Communications, 10.1093/braincomms/fcac027, Vol. 4, No. 2, Online publication date: 1-Mar-2022. Obstructive sleep apnea and severe COVID-19 infection: is there a plausible link?Sahni A and Cao M Journal of Clinical Sleep Medicine, Vol. 17, No. 11, (2145-2146), Online publication date: 1-Nov-2021.Concern about sleep disorders in underresourced settings is imminentZeng L, Chen R, Hu L, Wang D, Chen M, Lai Y, Lin J, Lin J, Li N, Zeng Y and Zheng Z Journal of Clinical Sleep Medicine, Vol. 17, No. 11, (2339-2340), Online publication date: 1-Nov-2021.Evaluating consumer and clinical sleep technologies: an American Academy of Sleep Medicine updateSchutte-Rodin S, Deak M, Khosla S, Goldstein C, Yurcheshen M, Chiang A, Gault D, Kern J, O'Hearn D, Ryals S, Verma N, Kirsch D, Baron K, Holfinger , Miller J, Patel R, Bhargava S and Ramar K Journal of Clinical Sleep Medicine, Vol. 17, No. 11, (2275-2282), Online publication date: 1-Nov-2021.The "Traffic Light OSA-SARS": a tool for the management of obstructive sleep apnea in the pandemic eraSanna A, Foresi A, Siciliano M, Torchio R, Attinà A, Giovanna Battaglia E, Bellofiore S, Bertocco E, Bevilacqua S, Bosi M, Bradicich M, Cerveri I, Ciacco C, Corsico A, Crudele P, D'Amico I, D'Intino D, Di Michele L, Fois A, Foresi A, Gatti E, Greco A, Lacedonia D, Launora N, Mantero M, Marino L, Melani A, Milanese M, Emanuele Polistina G, Polla B, Privitera S, Ranieri P, Re A, Sanna A, Schino P, Schisano M, Schisano M, Siciliano M, Spicuzza L, Maurizio Toraldo D, Torchio R, Tupputi E and Rita Tusino A Journal of Clinical Sleep Medicine, Vol. 17, No. 11, (2337-2338), Online publication date: 1-Nov-2021.Apnea-hypopnea index vs oxygen desaturation index for diagnosis of obstructive sleep apnea in patients with atrial fibrillation: six of one, half a dozen of the other?Lin C and Yu C Journal of Clinical Sleep Medicine, Vol. 17, No. 11, (2333-2334), Online publication date: 1-Nov-2021.Guiding principles for determining work shift duration and addressing the effects of work shift duration on performance, safety, and health: guidance from the American Academy of Sleep Medicine and the Sleep Research SocietyGurubhagavatula I, Barger L, Barnes C, Basner M, Boivin D, Dawson D, Drake C, Flynn-Evans E, Mysliwiec V, Patterson P, Reid K, Samuels C, Shattuck N, Kazmi U, Carandang G, Heald J and Van Dongen H Journal of Clinical Sleep Medicine, Vol. 17, No. 11, (2283-2306), Online publication date: 1-Nov-2021.Impacts of travel distance and travel direction on back-to
Referência(s)